Our Founder Story
For more than seventy years, protection from X-ray radiation has stagnated, with companies offering only modified shield designs and more lead armor. Radiaction Medical has pursued an entirely new model with Radiaction, a device that attaches to the C-arm* to block scatter radiation at the source. Based in Tel Aviv, Israel, it was founded in 2016 by a physician and accomplished innovator, Amir Belson, MD, whose goal is to ensure that every aspect of its technology places physicians and clinical staff first.
*The Radiaction shield system has received FDA clearance for use with Toshiba Infinix-I or Siemens Artis C-arms
Our Mission
Engineering excellence allows us to surmount real-world challenges and limitations to make a lasting impact. Radiaction Medical draws on medical expertise and high-powered engineering to reduce the serious health risks the entire interventional staff now faces from daily radiation exposure while treating patients. One system protects all.
Our Product
In a complete departure from current solutions that shield or clothe users to block radiation, Radiaction Medical created Radiaction, a plug-and-play accessory to block radiation at the source. It achieves an average reduction of 90% in scatter radiation, thus offering head-to-toe protection for everyone in the room. It has received FDA Class II clearance and CE marking and is currently available in the United States, the European Union (EU), and the United Kingdom (UK).
Our Leadership
Jonathan Yifat
Dr. Amir Belson MD
Remo Almog
Jonathan Yifat
Since its inception, Mr. Yifat has led Radiaction, from concept to product, through regulation and quality, to fundraising and business development. With over 12 years of experience in R&D management, Jonathan has a unique mix of hands-on experience and strategic overview.
Before Radiaction, Jonathan was director of the R&D team in the Ballistic Missile Defense field at WALES Ltd, heading cutting-edge studies for Departments of Defense of various countries.
Jonathan received his BSc in Physics and Business Administration and MSc in Bio-Medical Engineering, all with honors, from Tel Aviv University.
Mr. Yifat was a regular keynote speaker at professional conferences worldwide and published several papers and patents in missile defense and medical technologies.
Dr. Amir Belson MD
Amir Belson, M.D., founded Neoguide Systems, which Intuitive Surgical acquired in 2009. Vascular Pathways, a vascular intervention technology acquired by C R Bard. Zipline Medical, a wound closure technology company, was acquired by Stryker. Qool Therapeutics is a minimally invasive therapeutic hypothermia technology company. Radiaction Medical is a radiation protection medical device company. Emboline, which develops proprietary embolic protection technology. Modular Surgical develops new minimally invasive surgery technology, and PAFA develops atrial fibrillation ablation technology.
Dr. Belson also serves as a board director of Relimetrics and QT Vascular.
Belson graduated cum laude from the School of Medicine of the Technion, Israel Institute of Technology, in Haifa, Israel. He did his pediatric residency at Dana Children's Hospital in Tel Aviv and his pediatric nephrology fellowship at Lucile Packard Children's Hospital at Stanford University. Belson also spent one year as a research fellow with Stanford's Biomedical Technology Innovation Program.
He is the author of 34 medical papers and abstracts and has more than 750 issued and pending patents.
Remo Almog
Mr. Almog has over 18 years of extensive experience leading R&D and Operations teams in medical devices. During his career, Almog has gained vast experience with the full product life cycle, including responsibility for product definition, product development, and product manufacturing in cardiovascular and multidisciplinary companies.
Almog held executive positions at Eximo medical, which was acquired by Angiodynamics (served as the company’s COO); MValve technologies (served as a Director of R&D); Valve Medical (served as an R&D team leader) and Corassist cardiovascular (served as R&D engineer).
Mr. Almog holds a B.Sc. in Mechanical Engineering from Ben Gurion University and an M.Sc in Mechanical Engineering and Management from Tel Aviv University.
Christopher Barys
Hila Angel
Christopher Barys
Christopher Barys has diverse work experience spanning several industries. Before Radiaction, Christopher served as the President and CEO of On Target Laboratories, Inc. He was the Senior Vice President and Business Leader for Image Guided Therapy - Devices at Philips Health Systems North America, where he played a crucial role in developing workflow solutions for healthcare challenges in cardiology, peripheral vascular, and structural heart fields.
Christopher also served as Medtronic's Vice President and General Manager of Interventional Lung Solutions, COO and Executive Vice President at FlowCardia Inc., Vice President of Sales and Marketing at Edwards Lifesciences, Director of U.S. Sales at Cordis Cardiology, and Sales Manager/Sales Representative at Schneider Worldwide. Additionally, Barys was a Board of Director member at Urologix, Inc.
Christopher attended Northern Illinois University, where he pursued a field of study in Marketing.
Hila Angel
Hila joins the executive leadership team bringing vast finance experience to a variety of organizations ranging from publicly traded companies to startups. She has spent her career managing the financial aspects of several businesses, including accounting, FP&A, reporting, and process implementation. Hila excels in managing and optimizing company business processes and is extremely organized and diligent. Hila is inspired by the Radiaction mission and joined us because she wanted to work on an innovative and dynamic team.
Hila is a CPA with a B.A. in Accounting, a B.A. in Economics & Business Management, and an LL.M., Master of Laws, from Bar-Ilan University.
Lead Investor
